Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		123 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Revenues
Product sales	$ 0	$ 47,400	$ 894,518
Grant revenues	0	0	1,623,160
Total revenues	0	47,400	2,517,678
Cost of goods sold	0	(30,020)	(506,225)
Gross profit	0	17,380	2,011,453
Operating expenses
Research and development	243,544	724,876	46,287,642
Selling, general and administrative	1,194,945	1,267,757	49,657,222
Total operating expenses	1,438,489	1,992,633	95,944,864
Loss from operations	(1,438,489)	(1,975,253)	(93,933,411)
Change in fair value of derivative liabilities	0	0	10,395,709
Gain on warrant exchange	0	0	473,872
Interest income	0	217	1,583,855
Interest expense	0	(771)	(7,127,025)
Net loss from continuing operations	(1,438,489)	(1,975,807)	(88,607,000)
Net loss from discontinued operations	0	(286,548)	(24,568,710)
Gain on sale of business unit	0	0	6,408,603
Net loss	$ (1,438,489)	$ (2,262,355)	$ (106,767,107)
Net loss per share-basic and diluted
Net loss from continued operations	$ (0.16)	$ (0.31)
Net Loss from discontinued operations	$ 0.00	$ (0.04)
Net loss per share-basic and diluted	$ (0.16)	$ (0.35)
Weighted average number of common shares outstanding	9,037,771	6,377,538